Literature DB >> 22127688

Lupus: how much "complexity" is really (just) genetic heterogeneity?

Yanick J Crow1.   

Abstract

Mesh：

Year:  2011        PMID： 22127688     DOI： 10.1002/art.30603

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  6 in total

1.  Pediatric rheumatic disease: Treating lupus nephritis in children--is there a gold standard?

Authors:  Rolando Cimaz
Journal:  Nat Rev Rheumatol       Date:  2012-02-28       Impact factor: 20.543

Review 2.  Intracellular Nucleic Acid Detection in Autoimmunity.

Authors:  John T Crowl; Elizabeth E Gray; Kathleen Pestal; Hannah E Volkman; Daniel B Stetson
Journal:  Annu Rev Immunol       Date:  2017-01-30       Impact factor: 28.527

Review 3.  Solving the genetic puzzle of systemic lupus erythematosus.

Authors:  Wanling Yang; Yu Lung Lau
Journal:  Pediatr Nephrol       Date:  2014-09-20       Impact factor: 3.714

4.  Protein kinase cδ deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation.

Authors:  Alexandre Belot; Paul R Kasher; Eleanor W Trotter; Anne-Perrine Foray; Anne-Laure Debaud; Gillian I Rice; Marcin Szynkiewicz; Marie-Therese Zabot; Isabelle Rouvet; Sanjeev S Bhaskar; Sarah B Daly; Jonathan E Dickerson; Josephine Mayer; James O'Sullivan; Laurent Juillard; Jill E Urquhart; Shameem Fawdar; Anna A Marusiak; Natalie Stephenson; Bohdan Waszkowycz; Michael W Beresford; Leslie G Biesecker; Graeme C M Black; Céline René; Jean-François Eliaou; Nicole Fabien; Bruno Ranchin; Pierre Cochat; Patrick M Gaffney; Flore Rozenberg; Pierre Lebon; Christophe Malcus; Yanick J Crow; John Brognard; Nathalie Bonnefoy
Journal:  Arthritis Rheum       Date:  2013-08

Review 5.  The type I interferonopathies: 10 years on.

Authors:  Yanick J Crow; Daniel B Stetson
Journal:  Nat Rev Immunol       Date:  2021-10-20       Impact factor: 108.555

Review 6.  Cause and consequences of the activated type I interferon system in SLE.

Authors:  Maija-Leena Eloranta; Lars Rönnblom
Journal:  J Mol Med (Berl)       Date:  2016-04-20       Impact factor: 4.599
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.